Vycor Medical (VYCO) Return on Capital Employed Growth (3y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -1,962.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 214.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 31.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 355.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -846.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,318.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -247.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 362.00 |
| 10 | Vycor Medical | - | - | 375,153.00 | -975.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -975.00 |
| Dec 31, 2025 | -1,202.00 |
| Sep 30, 2025 | -1,605.00 |
| Jun 30, 2025 | -1,586.00 |
| Mar 31, 2025 | -1,096.00 |
| Dec 31, 2024 | -1,951.00 |
| Sep 30, 2024 | -1,911.00 |
| Jun 30, 2024 | -2,543.00 |
| Mar 31, 2024 | -3,855.00 |
| Dec 31, 2023 | -4,329.00 |
| Sep 30, 2023 | -4,024.00 |
| Jun 30, 2023 | -4,375.00 |
| Mar 31, 2023 | -3,464.00 |
| Dec 31, 2022 | -3,560.00 |
| Sep 30, 2022 | -6,008.00 |
| Jun 30, 2022 | -7,438.00 |
| Mar 31, 2022 | -10,131.00 |
| Dec 31, 2021 | -20,478.00 |
| Sep 30, 2021 | -22,654.00 |
| Jun 30, 2021 | -67,987.00 |
| Mar 31, 2021 | -50,244.00 |
| Dec 31, 2020 | 62,080.00 |
| Sep 30, 2020 | 35,272.00 |
| Jun 30, 2020 | 19,188.00 |
| Mar 31, 2020 | 34,578.00 |
| Dec 31, 2019 | 7.14 Mn |
| Sep 30, 2019 | 40,190.00 |
| Jun 30, 2019 | 33,773.00 |
| Mar 31, 2019 | 28,553.00 |
| Mar 31, 2018 | 62,892.00 |
| Jun 30, 2017 | -7,503.00 |
| Mar 31, 2017 | 4,006.00 |
| Dec 31, 2016 | -7.14 Mn |
| Sep 30, 2016 | -40,558.00 |
| Jun 30, 2016 | -35,434.00 |
| Mar 31, 2016 | -30,713.00 |
| Mar 31, 2015 | 87,999.00 |